Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, CHC Healthcare Group's Enterprise Value is NT$9,347 Mil.
CHC Healthcare Group's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 was NT$467 Mil. Therefore, CHC Healthcare Group's EV-to-EBIT ratio for today is 20.03.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, CHC Healthcare Group's Enterprise Value is NT$9,347 Mil.
CHC Healthcare Group's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was NT$1,129 Mil. Therefore, CHC Healthcare Group's EV-to-EBITDA ratio for today is 8.28.
*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.
CHC Healthcare Group (TPE:4164) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
CHC Healthcare Group's current Enterprise Value is NT$9,347 Mil.
CHC Healthcare Group's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$467 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
CHC Healthcare Group's current Enterprise Value is NT$9,347 Mil.
CHC Healthcare Group's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$1,129 Mil.
CHC Healthcare Group's current Enterprise Value is NT$9,347 Mil.
CHC Healthcare Group's Revenue for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$4,551 Mil.
CHC Healthcare Group's current Enterprise Value is NT$9,347 Mil.
CHC Healthcare Group's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$634 Mil.
CHC Healthcare Group's current Enterprise Value is NT$9,347 Mil.
CHC Healthcare Group's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$-93 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CHC Healthcare Group Enterprise Value Related Terms
CHC Healthcare Group Enterprise Value Historical Data
* Premium members only.
The historical data trend for CHC Healthcare Group's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TPE:4164 vs MCK, COR, CAH: Enterprise Value Comparison
For the Medical Distribution subindustry, CHC Healthcare Group's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
CHC Healthcare Group Enterprise Value vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, CHC Healthcare Group's Enterprise Value distribution charts can be found below:
* The bar in red indicates where CHC Healthcare Group's Enterprise Value falls into.
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
CHC Healthcare Group's Enterprise Value for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Enterprise Value of NT$9,347 Mil mean?
CHC Healthcare Group (TPE:4164) has a Enterprise Value of NT$9,347 Mil as of Aug. 03, 2026. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on CHC Healthcare Group and its competitors.
Is CHC Healthcare Group's Enterprise Value too high?
CHC Healthcare Group's current Enterprise Value is NT$9,347 Mil. Overall, CHC Healthcare Group has a GF Score™ of 76/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does CHC Healthcare Group's Enterprise Value compare to MCK and COR?
CHC Healthcare Group's Enterprise Value of NT$9,347 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Enterprise Value for a Medical Distribution company?
A good Enterprise Value depends on the Medical Distribution industry context. However, Enterprise Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Enterprise Value mean?
A high Enterprise Value can signal that a stock is expensive relative to its fundamentals. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on CHC Healthcare Group and its competitors. CHC Healthcare Group's current Enterprise Value is NT$9,347 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CHC Healthcare Group stock overvalued right now?
Based on GuruFocus' analysis, CHC Healthcare Group (TPE:4164) is currently considered Possible Value Trap. The stock's GF Value™ is NT$52.32, compared to a current price of NT$26.05 — trading 50.2% below its estimated fair value. The current Enterprise Value is NT$9,347 Mil. CHC Healthcare Group's overall GF Score™ is 76/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Enterprise Value calculated?
Enterprise Value is calculated from a company's financial statements. For CHC Healthcare Group (TPE:4164), the current Enterprise Value is NT$9,347 Mil as of Aug. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is CHC Healthcare Group (TPE:4164) Overvalued in 2026?
Based on GuruFocus' analysis, CHC Healthcare Group stock appears to be undervalued.
The current stock price of NT$26.05 is trading 50.2% below its estimated GF Value™ of NT$52.32.
GuruFocus considers CHC Healthcare Group to be Possible Value Trap.
Key valuation signals for TPE:4164:
Enterprise Value: NT$9,347 Mil
GF Value™: NT$52.32 vs. price of NT$26.05 (50.2% below fair value)
No single metric tells the full story. See the TPE:4164 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
CHC Healthcare Group is a Taiwan-based company engaged in the trading of pharmaceutical products and health food, as well as the sale, leasing, installation, and repair of medical instruments. It is engaged in the distribution of radiotherapy equipment, including equipment used in radiation oncology, ophthalmology, dentistry, and neuroscience. It also provides medical equipment consulting for hospitals and clinics. It earns revenues from the sale of drugs, the sale of medical instruments, repairs, maintenance, and other services.
76GF Score
Get the complete analysis for TPE:4164
Enterprise Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:4164 has been successfully added to your 
